References
- Grubb A, Löfberg H. Human γ-trace, a basic micro protein: Amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci USA 1982;79:3024–7.
- Grubb A. Cystatin C. In Haeberli A (editor). Human protein data. VCH Verlagsgesellschaft mbH, Weinheim. 2. Installment 1993.
- Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M, Jaskolski, M. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol 2001;8:316–20.
- Abrahamson M, Dalboge H, Olafsson I, Carlsen S, Grubb A. Efficient production of native, biologically active human cystatin C by Escherichia coli. Febs Letters 1988;236: 14–18.
- Blirup-Jensen S, Grubb A, Lindström V, Schmidt C, Althaus H. Standardization of cystatin C: development of primary and secondary reference preparations. Scand J Clin Lab Invest 2008;68:67–70.
- Grubb A. Cystatin C as a biomarker in kidney disease. In Edelstein CL (editor). Biomarkers Oxford: Elsevier, 2011: 291–312. ISBN: 978-0-12-375672-5.
- Grubb A. Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: simultaneous use of cystatin C- and creatinine-based GFR-prediction equations, clinical data and an internal quality check. Scand J Clin Lab Invest 2010;70:65–70.
- Löfberg H, Grubb A. Quantitation of γ-trace in human biological fluids: indications for production in the central nervous system. Scand J Clin Lab Invest 1979;39:619–26.
- Hall A, Håkansson K, Mason RW, Grubb A, Abrahamson M. Structural basis for the biological specificity of cystatin C – identification of leucine-9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases. J Biol Chem 1995;270: 5115–21.
- Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindström V, Grubb A. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40:1921–6.
- Boys BL, Kuprowski MC, Noel JJ, Konermann L. Protein oxidative modifications during electrospray ionization: solution phase electrochemistry or corona discharge-induced radical attack? Anal Chem 2009;81:4027–34.
- Jeppsson JO, Kobold U, Barr J, Finke A, Hoelzel W, Hoshino T, Miedema K, Mosca A, Mauri P, Paroni R, Thienpont L, Umemoto M, Weykamp C, on behalf of the International Federation of Clinical Chemistry Laboratory Medicine. Approved IFCC reference method for the measurement of HbA(1c) in human blood. Clin Chem Lab Med 2002;40:78–89.
- Stokvis E, Rosing H, Beijnen JH. Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not? Rapid Commun Mass Sp 2005;19:401–7.
- Swinkels DW, Girelli D, Laarakkers C, Kroot J, Campostrini N, Kemna E, Tjalsma, H. Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. Plos One 2008;3:e2706.
- Grubb A, Blirup-Jensen S, Lindström V, Schmidt C, Althaus H, Zegers I on behalf of the IFCC Working Group on standardisation of cystatin C (WG-SCC): First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med 2010;48:1619–21.
- Zegers I, Auclair G, Schimmel H, Emons H, Blirup-Jensen S, Schmidt C, Lindström V, Grubb A, Althaus H. Certification of cystatin C in the human serum reference material ERM-DA471/IFCC. EUR 24408 EN. Luxembourg: European Communities 2010:1–26. ISBN 978-92-79-07562-9.
- Hoofnagle AN, Wener MH. The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry. J Immunol Methods 2009;347:3–11.
- Gorres KL, Raines RT. Prolyl 4-hydroxylase. Crit Rev Biochem Mol 2010;45:106–24.
- Hudson DM, Eyre DR. Collagen prolyl 3-hydroxylation: a major role for a minor post-translational modification? Connect Tissue Res 2013;54:245–51.